Type 2 & other diabetes

Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA1c levels but not with type 2 diabetes

DiabetologiaPublished Cross-sectional study

Main finding · HbA1c (UK Biobank)Result — go to the resultβ 0.087 SD 95% CI 0.039–0.135

Authors' conclusion

The higher type 2 diabetes prevalence previously observed in carriers of missense MTNR1B variants causing impairment in MT2 signalling was not replicated in the UK Biobank, yet carriers had elevated HbA1c levels.

Study context

Population
UK Biobank participants (glycaemic phenotypes without diabetes; other cardiometabolic phenotypes; T2D case-control); Danish Inter99 participants without diabetes; DD2 cohort cases; recall-by-genotype study of individuals without diabetes
Exposure
Carriers of MTNR1B variants vs non-carriers
Outcome
HbA1c (UK Biobank)
Methodological detailsvariant burden testing, case-control study, recall-by-genotype study
  • Variant burden testing
  • Case-control study
  • Recall-by-genotype study

Main finding

As reported in the abstract

β

0.087 SD

95% CI 0.039–0.135

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Glucose-stimulated insulin response, carriers of variants impairing MT2 signallingNominally significant lower responseβ −0.47 SD (95% CI −0.82 to −0.11)
Insulin response after melatonin treatment (recall-by-genotype)Carriers vs Non-carriersβ −476.0 (95% CI −928.6 to −24.4)
Insulin response after melatonin treatment (recall-by-genotype)rs10830963 carriers vs Non-carriers · reduced responseβ −390.8 (95% CI −740.1 to −41.6)
  • Insulin response after melatonin treatment (recall-by-genotype): reduced response in carriers of variants impairing MT2 signalling

Glycaemic phenotypes (Inter99)

No significant associations with glycaemic phenotypes in Inter99

Original publication

Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA1c levels but not with type 2 diabetes. Diabetologia. Published 10 March 2025. doi:10.1007/s00125-025-06381-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.